Kla Corp
10 nominees · 3 ballot items.
Election of ten directors nominated by the Board; ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2026; and advisory approval of the named executive officer compensation.
Follow how the vote landed and what changed on Kla Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of 10 Directors Named in this Proxy Statement
ManagementBoard: FORElection of ten director nominees to serve one-year terms on the Board
- 2
Ratification of Appointment of PricewaterhouseCoopers LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending June 30, 2026
ManagementBoard: FORRatify the appointment of PricewaterhouseCoopers LLP as KLA's independent registered public accounting firm for FY ending June 30, 2026.
- 3
Approval of Our Named Executive Officer Compensation
ManagementBoard: FORAdvisory vote to approve the compensation of our Named Executive Officers as disclosed in the proxy statement.
Nominees on the ballot10
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 0.7% | 8,519,374 | $12.5B |
| 2 | STATE STREET CORP | 0.5% | 6,153,503 | $9.1B |
| 3 | BlackRock, Inc. | 0.4% | 5,417,014 | $8.0B |
| 4 | Capital World Investors | 0.3% | 4,084,069 | $6.0B |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 0.3% | 4,029,061 | $5.9B |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 0.2% | 3,263,859 | $4.8B |
| 7 | FMR LLC | 0.2% | 2,916,981 | $4.3B |
| 8 | Capital International Investors | 0.2% | 2,728,138 | $4.0B |
| 9 | BlackRock, Inc. | 0.2% | 2,721,879 | $4.0B |
| 10 | PRIMECAP MANAGEMENT CO/CA/ | 0.2% | 2,437,647 | $3.6B |
Other Technology sector meetings6
Upcoming shareholder meetings at Kla Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Kla Corp 2025 annual meeting?
- Kla Corp (KLAC) holds its 2025 annual shareholder meeting on Wednesday, November 5, 2025.
- What is the record date for the Kla Corp 2025 meeting?
- The record date for the Kla Corp 2025 meeting is Wednesday, September 10, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Kla Corp's 2025 meeting?
- The board is presenting 10 director nominees at the Kla Corp 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Kla Corp 2025 meeting?
- Shareholders will vote on 3 proposals at the Kla Corp 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.